Toshimasa Asahara
Overview
Explore the profile of Toshimasa Asahara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
2275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimura M, Chimed-Ochir O, Yumiya Y, Ohge H, Shime N, Sakaguchi T, et al.
Int J Environ Res Public Health
. 2021 Sep;
18(17).
PMID: 34501719
With the widespread and increasing number of cases of Coronavirus Disease (2019) globally, countries have been taking preventive measures against this pandemic. However, there is no universal agreement across cultures...
2.
Kusano M, Aoyama T, Okabayashi K, Hirata K, Tsuji Y, Nakamori S, et al.
J Cancer Res Ther
. 2018 Sep;
14(Supplement):S761-S766.
PMID: 30249900
Aim: This randomized phase III trial compared hepatic arterial infusion (HAI) chemotherapy with 5-fluorouracil (5-FU) followed by uracil/tegafur (UFT) and leucovorin (LV) versus UFT/LV alone for patients with curatively resected...
3.
Tateno C, Miya F, Wake K, Kataoka M, Ishida Y, Yamasaki C, et al.
Lab Invest
. 2012 Nov;
93(1):54-71.
PMID: 23147226
We previously produced mice with human hepatocyte (h-hep) chimeric livers by transplanting h-heps into albumin enhancer/promoter-driven urokinase-type plasminogen activator-transgenic severe combined immunodeficient (SCID) mice with liver disease. The chimeric livers...
4.
Marubashi S, Umeshita K, Asahara T, Fujiwara K, Haga H, Hashimoto T, et al.
Clin Transplant
. 2012 Apr;
26(6):857-67.
PMID: 22507465
This prospective, non-randomized, multicenter cohort study analyzed the safety and efficacy of a steroid-free immunosuppressive (IS) protocol for hepatitis C virus (HCV)-positive living donor liver transplant (LDLT) recipients in Japan....
5.
Tashiro H, Aikata H, Waki K, Amano H, Oshita A, Kobayashi T, et al.
J Surg Oncol
. 2011 Jun;
104(1):3-9.
PMID: 21656523
Background: The preferred choice between surgical treatment and radiofrequency ablation (RFA) for the treatment of small resectable hepatocellular [corrected] carcinoma (HCC) has become a subject for debate. Methods: We compared...
6.
Amano H, Tashiro H, Oshita A, Kobayashi T, Tanimoto Y, Kuroda S, et al.
J Gastrointest Surg
. 2011 Apr;
15(7):1173-81.
PMID: 21512850
Background: The appropriate treatment strategy for advanced hepatocellular carcinoma (HCC) that does not meet the Milan criteria (MC) is unclear. The aim of this study was to determine the significance...
7.
Matsumoto T, Hayamizu K, Marubayashi S, Shimizu K, Hamamoto A, Yamaguchi T, et al.
J Clin Biochem Nutr
. 2011 Mar;
48(2):134-41.
PMID: 21373266
Lipopolysaccharide-stimulated leukocytes secrete proinflammatory cytokines including tumor necrosis factor-α and interleukin-12. Over-activation of host defense systems may result in severe tissue damage and requires regulation. Granulocyte colony-stimulating factor and interleukin-10...
8.
Amano H, Hino H, Tateno C, Emoto K, Imaoka Y, Yamasaki C, et al.
J Surg Res
. 2011 Feb;
167(1):e29-37.
PMID: 21324401
Background: This study aimed to evaluate the therapeutic potential of intrasplenic transplantation of culture-propagated homologous hepatocytes in rats suffering from acute liver failure (ALF). Methods: ALF was induced in dipeptidyl...
9.
Tateno C, Kataoka M, Utoh R, Tachibana A, Itamoto T, Asahara T, et al.
Endocrinology
. 2011 Feb;
152(4):1479-91.
PMID: 21303949
Clinical studies have shown a close association between nonalcoholic fatty liver disease and adult-onset GH deficiency, but the relevant molecular mechanisms are still unclear. No mouse model has been suitable...
10.
Yamasaki C, Kataoka M, Kato Y, Kakuni M, Usuda S, Ohzone Y, et al.
Drug Metab Pharmacokinet
. 2010 Oct;
25(6):539-50.
PMID: 20930422
Cryopreserved human (h-) hepatocytes are currently regarded as the best in vitro model for predicting human intrinsic clearance of xenobiotics. Although fresh h-hepatocytes have greater plating efficiency on dishes and...